Nov 20, 2025Regeneron pledges $2B to New York expansion | Thermo Fisher launches CGT development center

Nov 19, 2025Swiss drugmakers subject to 15% pharma tariff | CSL to invest $1.5B in US manufacturing

Nov 18, 2025Pharma supply chain embraces AI | CDMO teaming looks to validate capsid platform

Nov 15, 2025Trump incentivizes Big Pharma to make deals | Legend Biotech opens cell therapy R&D site

Nov 14, 2025Has the time come for plant-based biologics? | The state of CDMO funding in 2025

Nov 13, 2025Lonza’s Vacaville site integration on plan | Ori Biotech teams with Seattle Children’s Research Institute

Nov 12, 2025Simtra’s dual-continent growth strategy | CGT manufacturing challenges, opportunities

Nov 11, 2025NC ranks best for biologics manufacturing | Novartis opens radioligand facility, part of $23B US expansion

Nov 8, 2025US capacity needed for smaller biotechs | Biovectra, Revolution Biomanufacturing partner

Nov 7, 2025Fujifilm taps automated downstream purification system | Cencora spends $1B to expand US drug distribution

Nov 6, 2025Startup raises $1.3B, targets biomanufacturing | Catalent unveils new class of ADCs

Nov 5, 2025CDMOs poised for growth in 2026 | Lilly to build $3B manufacturing facility in Netherlands

Nov 4, 20252025 Pharma Innovation Awards | AstraZeneca, Lilly, Merck fund workforce development

Nov 1, 2025Fujifilm’s Denmark site is 100% solar powered | Ajinomoto, Astellas ink ADC deal

Oct 31, 2025Lilly invests $1.2B in Puerto Rico site | Resilience secures $825M for biologics shift

Oct 30, 2025CDMOs in China, US to see fastest growth | Recipharm gets Gates grant for AI-enabled manufacturing

Oct 29, 2025Catalent launches new corporate brand | Lonza to acquire Redberry SAS

Oct 28, 2025The state of biopharma resilience in 2025 | Hovione doubles US spray drying capacity

Oct 25, 2025Lonza, Thermo Fisher report strong Q3 | Galderma to invest $650M in US manufacturing

Oct 24, 2025Lonza reports strong CDMO performance in Q3 | Sharp invests $100M in US, European sites

Oct 23, 2025Thermo Fisher expects benefit from customers’ US investment | Cambrex invests $120M in US operations

Oct 22, 2025MilliporeSigma positions for ADC growth | ACG invests $200M in its first US empty-capsule facility

Oct 21, 2025Key starting material dependence puts US at risk | Merck breaks ground on $3B Virginia plant

Oct 18, 2025Novo Nordisk’s Indiana plant has history of issues | FDA priority vouchers target US manufacturing

Oct 17, 2025Charles River adjusts to headwinds in CDMO business | AstraZeneca invests $445M in Texas plant

Latest Edition